PHARMACOKINETIC CHANGES DURING HYPOTHERMIA
ESPNIC Academy. Pokorna P. 06/14/13; 31748 Topic: Pharmacology
Pavla Pokorna
Pavla Pokorna
Access to this content is currently an ESPNIC membership benefit.

Click here to join ESPNIC or renew your membership.
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
After viewing this presentation the participant will be able to:
-Describe the impact of hypothermia on pharmacokinetics (Pk) and pharmacodynamics (PD) in neonates
-Discuss the role of PK and PD in optimizing regimens under hypothermia conditions
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies